APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunity Support Ingredients

As the spread of COVID-19 outside China increased, consumers are interested in immunization. With the search for ways to strengthen the immune system, activities in this field are booming, especially vitamin C. In the past few months, the demand for immunity support products increased dramatically.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

As the spread of COVID-19 outside China increased, consumers are interested in immunization. With the search for ways to strengthen the immune system, activities in this field are booming, especially vitamin C. In the past few months, the demand for immunity support products increased dramatically.

Selected research

Market Analysis & Forecast

Global Immunity Support Ingredients Market Analysis and Forecast 2026-2032

30 December 2025216 pages

Choose your research edition.

Industry ResearchImmunity Support Ingredients Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunity Support Ingredients Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Immunity Support Ingredients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunity Support Ingredients Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunity Support Ingredients Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

As the spread of COVID-19 outside China increased, consumers are interested in immunization. With the search for ways to strengthen the immune system, activities in this field are booming, especially vitamin C. In the past few months, the demand for immunity support products increased dramatically.

From the perspective of manufacturers, the main global players of support innovations are DSM, BASF, Cargill, Kerry, Kemin, Croda, Zhejiang NHU, Chr. Hansen, Shandong Luwei, CSPC Pharma, Allied Biotech, Zhengjiang Medicine, Dohler, etc. In 2019, the global top five players are DSM, BASF, Zhejiang NHU, Croda and CSPC Pharma, with 44.78% market share of revenue. Among them, DSM is the largest manufacturers of Immunity Support Ingredients.DSM occupied about 23% of the global Immunity Support Ingredients market.

Report Includes

Read the full market overview

This report presents an overview of global market for Immunity Support Ingredients, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Immunity Support Ingredients, also provides the revenue of main regions and countries. Of the upcoming market potential for Immunity Support Ingredients, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immunity Support Ingredients revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immunity Support Ingredients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Immunity Support Ingredients revenue, projected growth trends, production technology, application and end-user industry.

Immunity Support Ingredients Segment by Company

DSM

BASF

Zhejiang NHU

Croda

CSPC Pharma

EPAX

Adisseo

Zhejiang Medicine

Raisio Group

Northeast Pharma

Shandong Luwei

Allied Biotech

Cargill

Anhui Tiger

Shandong Tianli

Kerry

Dohler

Kemin

Chenguang Biotech

FMC

Chr. Hansen

Excelvite

DDW

Immunity Support Ingredients Segment by Type

Vitamin C

Vitamin E

Other Vitamins

Beta Glucans

Carotenoids

Phytosterols

Omega-3 Fatty Acids

Immunity Support Ingredients Segment by Application

Nutrition Supplements

Foods & Beverages

Pharmaceuticals

Feeds

Pet Foods

Personal Care Products

Immunity Support Ingredients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunity Support Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunity Support Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunity Support Ingredients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Immunity Support Ingredients in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Immunity Support Ingredients company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunity Support Ingredients revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immunity Support Ingredients Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vitamin C Major Player Table 3. Vitamin E Major Player Table 4. Other Vitamins Major Player Table 5. Beta Glucans Major Player Table 6. Carotenoids Major Player Table 7. Phytosterols Major Player Table 8. Omega-3 Fatty Acids Major Player Table 9. Global Immunity Support Ingredients Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Nutrition Supplements Major Player Table 11. Foods & Beverages Major Player Table 12. Pharmaceuticals Major Player Table 13. Feeds Major Player Table 14. Pet Foods Major Player Table 15. Personal Care Products Major Player Table 16. Immunity Support Ingredients Industry Trends Table 17. Immunity Support Ingredients Industry Drivers Table 18. Immunity Support Ingredients Industry Opportunities and Challenges Table 19. Immunity Support Ingredients Industry Restraints Table 20. Global Immunity Support Ingredients Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 21. Global Immunity Support Ingredients Market Size by Region (2021-2026) & (US$ Million) Table 22. Global Immunity Support Ingredients Market Share by Region (2021-2026) Table 23. Global Immunity Support Ingredients Market Size by Region (2027-2032) & (US$ Million) Table 24. Global Immunity Support Ingredients Market Share by Region (2027-2032) Table 25. Global Immunity Support Ingredients Revenue by Players (US$ Million) & (2021-2026) Table 26. Global Immunity Support Ingredients Revenue Market Share by Players (2021-2026) Table 27. Global Immunity Support Ingredients Key Players Ranking, 2024 VS 2025 VS 2026 Table 28. Global Immunity Support Ingredients Key Players Headquarters & Area Served Table 29. Global Immunity Support Ingredients Players, Product Type & Application Table 30. Global Immunity Support Ingredients Players Establishment Date Table 31. Global Players Market Concentration Ratio (CR5 and HHI) Table 32. Global Immunity Support Ingredients by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Immunity Support Ingredients Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Immunity Support Ingredients Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Immunity Support Ingredients Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Immunity Support Ingredients Revenue Market Share by Type (2021-2026) Table 37. Global Immunity Support Ingredients Revenue Market Share by Type (2027-2032) Table 38. Global Immunity Support Ingredients Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Immunity Support Ingredients Revenue by Application (2021-2026) & (US$ Million) Table 40. Global Immunity Support Ingredients Revenue by Application (2027-2032) & (US$ Million) Table 41. Global Immunity Support Ingredients Revenue Market Share by Application (2021-2026) Table 42. Global Immunity Support Ingredients Revenue Market Share by Application (2027-2032) Table 43. DSM Company Information Table 44. DSM Business Overview Table 45. DSM Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. DSM Immunity Support Ingredients Product Portfolio Table 47. DSM Recent Development Table 48. BASF Company Information Table 49. BASF Business Overview Table 50. BASF Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. BASF Immunity Support Ingredients Product Portfolio Table 52. BASF Recent Development Table 53. Zhejiang NHU Company Information Table 54. Zhejiang NHU Business Overview Table 55. Zhejiang NHU Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Zhejiang NHU Immunity Support Ingredients Product Portfolio Table 57. Zhejiang NHU Recent Development Table 58. Croda Company Information Table 59. Croda Business Overview Table 60. Croda Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Croda Immunity Support Ingredients Product Portfolio Table 62. Croda Recent Development Table 63. CSPC Pharma Company Information Table 64. CSPC Pharma Business Overview Table 65. CSPC Pharma Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. CSPC Pharma Immunity Support Ingredients Product Portfolio Table 67. CSPC Pharma Recent Development Table 68. EPAX Company Information Table 69. EPAX Business Overview Table 70. EPAX Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. EPAX Immunity Support Ingredients Product Portfolio Table 72. EPAX Recent Development Table 73. Adisseo Company Information Table 74. Adisseo Business Overview Table 75. Adisseo Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Adisseo Immunity Support Ingredients Product Portfolio Table 77. Adisseo Recent Development Table 78. Zhejiang Medicine Company Information Table 79. Zhejiang Medicine Business Overview Table 80. Zhejiang Medicine Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Zhejiang Medicine Immunity Support Ingredients Product Portfolio Table 82. Zhejiang Medicine Recent Development Table 83. Raisio Group Company Information Table 84. Raisio Group Business Overview Table 85. Raisio Group Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Raisio Group Immunity Support Ingredients Product Portfolio Table 87. Raisio Group Recent Development Table 88. Northeast Pharma Company Information Table 89. Northeast Pharma Business Overview Table 90. Northeast Pharma Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Northeast Pharma Immunity Support Ingredients Product Portfolio Table 92. Northeast Pharma Recent Development Table 93. Shandong Luwei Company Information Table 94. Shandong Luwei Business Overview Table 95. Shandong Luwei Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Shandong Luwei Immunity Support Ingredients Product Portfolio Table 97. Shandong Luwei Recent Development Table 98. Allied Biotech Company Information Table 99. Allied Biotech Business Overview Table 100. Allied Biotech Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Allied Biotech Immunity Support Ingredients Product Portfolio Table 102. Allied Biotech Recent Development Table 103. Cargill Company Information Table 104. Cargill Business Overview Table 105. Cargill Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Cargill Immunity Support Ingredients Product Portfolio Table 107. Cargill Recent Development Table 108. Anhui Tiger Company Information Table 109. Anhui Tiger Business Overview Table 110. Anhui Tiger Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Anhui Tiger Immunity Support Ingredients Product Portfolio Table 112. Anhui Tiger Recent Development Table 113. Shandong Tianli Company Information Table 114. Shandong Tianli Business Overview Table 115. Shandong Tianli Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Shandong Tianli Immunity Support Ingredients Product Portfolio Table 117. Shandong Tianli Recent Development Table 118. Kerry Company Information Table 119. Kerry Business Overview Table 120. Kerry Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Kerry Immunity Support Ingredients Product Portfolio Table 122. Kerry Recent Development Table 123. Dohler Company Information Table 124. Dohler Business Overview Table 125. Dohler Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Dohler Immunity Support Ingredients Product Portfolio Table 127. Dohler Recent Development Table 128. Kemin Company Information Table 129. Kemin Business Overview Table 130. Kemin Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Kemin Immunity Support Ingredients Product Portfolio Table 132. Kemin Recent Development Table 133. Chenguang Biotech Company Information Table 134. Chenguang Biotech Business Overview Table 135. Chenguang Biotech Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Chenguang Biotech Immunity Support Ingredients Product Portfolio Table 137. Chenguang Biotech Recent Development Table 138. FMC Company Information Table 139. FMC Business Overview Table 140. FMC Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. FMC Immunity Support Ingredients Product Portfolio Table 142. FMC Recent Development Table 143. Chr. Hansen Company Information Table 144. Chr. Hansen Business Overview Table 145. Chr. Hansen Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Chr. Hansen Immunity Support Ingredients Product Portfolio Table 147. Chr. Hansen Recent Development Table 148. Excelvite Company Information Table 149. Excelvite Business Overview Table 150. Excelvite Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Excelvite Immunity Support Ingredients Product Portfolio Table 152. Excelvite Recent Development Table 153. DDW Company Information Table 154. DDW Business Overview Table 155. DDW Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. DDW Immunity Support Ingredients Product Portfolio Table 157. DDW Recent Development Table 158. North America Immunity Support Ingredients Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Immunity Support Ingredients Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Immunity Support Ingredients Revenue by Application (2021-2026) & (US$ Million) Table 161. North America Immunity Support Ingredients Revenue by Application (2027-2032) & (US$ Million) Table 162. North America Immunity Support Ingredients Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. North America Immunity Support Ingredients Revenue by Country (2021-2026) & (US$ Million) Table 164. North America Immunity Support Ingredients Revenue by Country (US$ Million) & (2027-2032) Table 165. Europe Immunity Support Ingredients Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Immunity Support Ingredients Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Immunity Support Ingredients Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Immunity Support Ingredients Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Immunity Support Ingredients Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Europe Immunity Support Ingredients Revenue by Country (2021-2026) & (US$ Million) Table 171. Europe Immunity Support Ingredients Revenue by Country (US$ Million) & (2027-2032) Table 172. China Immunity Support Ingredients Revenue by Type (2021-2026) & (US$ Million) Table 173. China Immunity Support Ingredients Revenue by Type (2027-2032) & (US$ Million) Table 174. China Immunity Support Ingredients Revenue by Application (2021-2026) & (US$ Million) Table 175. China Immunity Support Ingredients Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Immunity Support Ingredients Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Immunity Support Ingredients Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Immunity Support Ingredients Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Immunity Support Ingredients Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Immunity Support Ingredients Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Immunity Support Ingredients Revenue by Region (US$ Million) & (2021-2026) Table 182. Asia Immunity Support Ingredients Revenue by Region (US$ Million) & (2027-2032) Table 183. SAMEA Immunity Support Ingredients Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Immunity Support Ingredients Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Immunity Support Ingredients Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Immunity Support Ingredients Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Immunity Support Ingredients Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA Immunity Support Ingredients Revenue by Country (2021-2026) & (US$ Million) Table 189. SAMEA Immunity Support Ingredients Revenue by Country (US$ Million) & (2027-2032) Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Immunity Support Ingredients Image Figure 2. Global Immunity Support Ingredients Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunity Support Ingredients Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vitamin C Image Figure 5. Vitamin E Image Figure 6. Other Vitamins Image Figure 7. Beta Glucans Image Figure 8. Carotenoids Image Figure 9. Phytosterols Image Figure 10. Omega-3 Fatty Acids Image Figure 11. Global Immunity Support Ingredients Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Immunity Support Ingredients Market Size Share 2021 VS 2025 VS 2032 Figure 13. Nutrition Supplements Image Figure 14. Foods & Beverages Image Figure 15. Pharmaceuticals Image Figure 16. Feeds Image Figure 17. Pet Foods Image Figure 18. Personal Care Products Image Figure 19. Global Immunity Support Ingredients Market Size (US$ Million) & (2021-2032) Figure 20. Global Immunity Support Ingredients Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Immunity Support Ingredients Market Share by Region: 2021 VS 2025 VS 2032 Figure 22. Global Immunity Support Ingredients Players Revenue Share Top 10 and Top 5 in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Immunity Support Ingredients Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Immunity Support Ingredients Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Immunity Support Ingredients Revenue Market Share by Type (2021-2032) Figure 27. Global Immunity Support Ingredients Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Immunity Support Ingredients Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 29. Global Immunity Support Ingredients Revenue Market Share by Application (2021-2032) Figure 30. North America Immunity Support Ingredients Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. North America Immunity Support Ingredients Revenue Share by Type (2021-2032) Figure 32. North America Immunity Support Ingredients Revenue Share by Application (2021-2032) Figure 33. North America Immunity Support Ingredients Revenue Share by Country (2021-2032) Figure 34. United States Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Canada Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Mexico Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Europe Immunity Support Ingredients Revenue YoY Growth (2021-2032) & (US$ Million) Figure 38. Europe Immunity Support Ingredients Revenue Share by Type (2021-2032) Figure 39. Europe Immunity Support Ingredients Revenue Share by Application (2021-2032) Figure 40. Europe Immunity Support Ingredients Revenue Share by Country (2021-2032) Figure 41. Germany Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. France Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. U.K. Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Italy Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Spain Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Russia Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Netherlands Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. Nordic Countries Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. China Immunity Support Ingredients Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. China Immunity Support Ingredients Revenue Share by Type (2021-2032) Figure 51. China Immunity Support Ingredients Revenue Share by Application (2021-2032) Figure 52. Asia Immunity Support Ingredients Revenue YoY Growth (2021-2032) & (US$ Million) Figure 53. Asia Immunity Support Ingredients Revenue Share by Type (2021-2032) Figure 54. Asia Immunity Support Ingredients Revenue Share by Application (2021-2032) Figure 55. Asia Immunity Support Ingredients Revenue Share by Region (2021-2032) Figure 56. Japan Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. South Korea Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. India Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Australia Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Taiwan Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Southeast Asia Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. SAMEA Immunity Support Ingredients Revenue YoY Growth (2021-2032) & (US$ Million) Figure 63. SAMEA Immunity Support Ingredients Revenue Share by Type (2021-2032) Figure 64. SAMEA Immunity Support Ingredients Revenue Share by Application (2021-2032) Figure 65. SAMEA Immunity Support Ingredients Revenue Share by Country (2021-2032) Figure 66. Brazil Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Argentina Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Chile Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Colombia Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Peru Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Saudi Arabia Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Israel Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. UAE Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Turkey Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Iran Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Egypt Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2021-2032) Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Vitamin C
  • Vitamin E
  • Other Vitamins
  • Beta Glucans
  • Carotenoids
  • Phytosterols
  • Omega-3 Fatty Acids
Applications
  • Nutrition Supplements
  • Foods & Beverages
  • Pharmaceuticals
  • Feeds
  • Pet Foods
  • Personal Care Products
Companies covered
  • DSM
  • BASF
  • Zhejiang NHU
  • Croda
  • CSPC Pharma
  • EPAX
  • Adisseo
  • Zhejiang Medicine
  • Raisio Group
  • Northeast Pharma
  • Shandong Luwei
  • Allied Biotech
  • Cargill
  • Anhui Tiger
  • Shandong Tianli
  • Kerry
  • Dohler
  • Kemin
  • Chenguang Biotech
  • FMC
  • Chr. Hansen
  • Excelvite
  • DDW

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Immunity Support Ingredients Market by Type
  3. 1.2.1 Global Immunity Support Ingredients Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vitamin C
  5. 1.2.3 Vitamin E
  6. 1.2.4 Other Vitamins
  7. 1.2.5 Beta Glucans
  8. 1.2.6 Carotenoids
  9. 1.2.7 Phytosterols
  10. 1.2.8 Omega-3 Fatty Acids
  11. 1.3 Immunity Support Ingredients Market by Application
  12. 1.3.1 Global Immunity Support Ingredients Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Nutrition Supplements
  14. 1.3.3 Foods & Beverages
  15. 1.3.4 Pharmaceuticals
  16. 1.3.5 Feeds
  17. 1.3.6 Pet Foods
  18. 1.3.7 Personal Care Products
  19. 1.4 Assumptions and Limitations
  20. 1.5 Study Goals and Objectives
2 Immunity Support Ingredients Market Dynamics
  1. 2.1 Immunity Support Ingredients Industry Trends
  2. 2.2 Immunity Support Ingredients Industry Drivers
  3. 2.3 Immunity Support Ingredients Industry Opportunities and Challenges
  4. 2.4 Immunity Support Ingredients Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Immunity Support Ingredients Market Perspective (2021-2032)
  2. 3.2 Global Immunity Support Ingredients Growth Trends by Region
  3. 3.2.1 Global Immunity Support Ingredients Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Immunity Support Ingredients Market Size by Region (2021-2026)
  5. 3.2.3 Global Immunity Support Ingredients Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Immunity Support Ingredients Revenue by Players
  2. 4.1.1 Global Immunity Support Ingredients Revenue by Players (2021-2026)
  3. 4.1.2 Global Immunity Support Ingredients Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Immunity Support Ingredients Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Immunity Support Ingredients Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Immunity Support Ingredients Key Players Headquarters & Area Served
  7. 4.4 Global Immunity Support Ingredients Players, Product Type & Application
  8. 4.5 Global Immunity Support Ingredients Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Immunity Support Ingredients Market CR5 and HHI
  11. 4.6.3 2025 Immunity Support Ingredients Tier 1, Tier 2, and Tier 3
5 Immunity Support Ingredients Market Size by Type
  1. 5.1 Global Immunity Support Ingredients Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Immunity Support Ingredients Revenue by Type (2021-2032)
  3. 5.3 Global Immunity Support Ingredients Revenue Market Share by Type (2021-2032)
6 Immunity Support Ingredients Market Size by Application
  1. 6.1 Global Immunity Support Ingredients Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Immunity Support Ingredients Revenue by Application (2021-2032)
  3. 6.3 Global Immunity Support Ingredients Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 DSM
  2. 7.1.1 DSM Company Information
  3. 7.1.2 DSM Business Overview
  4. 7.1.3 DSM Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  5. 7.1.4 DSM Immunity Support Ingredients Product Portfolio
  6. 7.1.5 DSM Recent Developments
  7. 7.2 BASF
  8. 7.2.1 BASF Company Information
  9. 7.2.2 BASF Business Overview
  10. 7.2.3 BASF Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BASF Immunity Support Ingredients Product Portfolio
  12. 7.2.5 BASF Recent Developments
  13. 7.3 Zhejiang NHU
  14. 7.3.1 Zhejiang NHU Company Information
  15. 7.3.2 Zhejiang NHU Business Overview
  16. 7.3.3 Zhejiang NHU Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Zhejiang NHU Immunity Support Ingredients Product Portfolio
  18. 7.3.5 Zhejiang NHU Recent Developments
  19. 7.4 Croda
  20. 7.4.1 Croda Company Information
  21. 7.4.2 Croda Business Overview
  22. 7.4.3 Croda Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Croda Immunity Support Ingredients Product Portfolio
  24. 7.4.5 Croda Recent Developments
  25. 7.5 CSPC Pharma
  26. 7.5.1 CSPC Pharma Company Information
  27. 7.5.2 CSPC Pharma Business Overview
  28. 7.5.3 CSPC Pharma Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CSPC Pharma Immunity Support Ingredients Product Portfolio
  30. 7.5.5 CSPC Pharma Recent Developments
  31. 7.6 EPAX
  32. 7.6.1 EPAX Company Information
  33. 7.6.2 EPAX Business Overview
  34. 7.6.3 EPAX Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  35. 7.6.4 EPAX Immunity Support Ingredients Product Portfolio
  36. 7.6.5 EPAX Recent Developments
  37. 7.7 Adisseo
  38. 7.7.1 Adisseo Company Information
  39. 7.7.2 Adisseo Business Overview
  40. 7.7.3 Adisseo Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Adisseo Immunity Support Ingredients Product Portfolio
  42. 7.7.5 Adisseo Recent Developments
  43. 7.8 Zhejiang Medicine
  44. 7.8.1 Zhejiang Medicine Company Information
  45. 7.8.2 Zhejiang Medicine Business Overview
  46. 7.8.3 Zhejiang Medicine Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Zhejiang Medicine Immunity Support Ingredients Product Portfolio
  48. 7.8.5 Zhejiang Medicine Recent Developments
  49. 7.9 Raisio Group
  50. 7.9.1 Raisio Group Company Information
  51. 7.9.2 Raisio Group Business Overview
  52. 7.9.3 Raisio Group Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Raisio Group Immunity Support Ingredients Product Portfolio
  54. 7.9.5 Raisio Group Recent Developments
  55. 7.10 Northeast Pharma
  56. 7.10.1 Northeast Pharma Company Information
  57. 7.10.2 Northeast Pharma Business Overview
  58. 7.10.3 Northeast Pharma Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Northeast Pharma Immunity Support Ingredients Product Portfolio
  60. 7.10.5 Northeast Pharma Recent Developments
  61. 7.11 Shandong Luwei
  62. 7.11.1 Shandong Luwei Company Information
  63. 7.11.2 Shandong Luwei Business Overview
  64. 7.11.3 Shandong Luwei Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Shandong Luwei Immunity Support Ingredients Product Portfolio
  66. 7.11.5 Shandong Luwei Recent Developments
  67. 7.12 Allied Biotech
  68. 7.12.1 Allied Biotech Company Information
  69. 7.12.2 Allied Biotech Business Overview
  70. 7.12.3 Allied Biotech Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Allied Biotech Immunity Support Ingredients Product Portfolio
  72. 7.12.5 Allied Biotech Recent Developments
  73. 7.13 Cargill
  74. 7.13.1 Cargill Company Information
  75. 7.13.2 Cargill Business Overview
  76. 7.13.3 Cargill Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cargill Immunity Support Ingredients Product Portfolio
  78. 7.13.5 Cargill Recent Developments
  79. 7.14 Anhui Tiger
  80. 7.14.1 Anhui Tiger Company Information
  81. 7.14.2 Anhui Tiger Business Overview
  82. 7.14.3 Anhui Tiger Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Anhui Tiger Immunity Support Ingredients Product Portfolio
  84. 7.14.5 Anhui Tiger Recent Developments
  85. 7.15 Shandong Tianli
  86. 7.15.1 Shandong Tianli Company Information
  87. 7.15.2 Shandong Tianli Business Overview
  88. 7.15.3 Shandong Tianli Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Shandong Tianli Immunity Support Ingredients Product Portfolio
  90. 7.15.5 Shandong Tianli Recent Developments
  91. 7.16 Kerry
  92. 7.16.1 Kerry Company Information
  93. 7.16.2 Kerry Business Overview
  94. 7.16.3 Kerry Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Kerry Immunity Support Ingredients Product Portfolio
  96. 7.16.5 Kerry Recent Developments
  97. 7.17 Dohler
  98. 7.17.1 Dohler Company Information
  99. 7.17.2 Dohler Business Overview
  100. 7.17.3 Dohler Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Dohler Immunity Support Ingredients Product Portfolio
  102. 7.17.5 Dohler Recent Developments
  103. 7.18 Kemin
  104. 7.18.1 Kemin Company Information
  105. 7.18.2 Kemin Business Overview
  106. 7.18.3 Kemin Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Kemin Immunity Support Ingredients Product Portfolio
  108. 7.18.5 Kemin Recent Developments
  109. 7.19 Chenguang Biotech
  110. 7.19.1 Chenguang Biotech Company Information
  111. 7.19.2 Chenguang Biotech Business Overview
  112. 7.19.3 Chenguang Biotech Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Chenguang Biotech Immunity Support Ingredients Product Portfolio
  114. 7.19.5 Chenguang Biotech Recent Developments
  115. 7.20 FMC
  116. 7.20.1 FMC Company Information
  117. 7.20.2 FMC Business Overview
  118. 7.20.3 FMC Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  119. 7.20.4 FMC Immunity Support Ingredients Product Portfolio
  120. 7.20.5 FMC Recent Developments
  121. 7.21 Chr. Hansen
  122. 7.21.1 Chr. Hansen Company Information
  123. 7.21.2 Chr. Hansen Business Overview
  124. 7.21.3 Chr. Hansen Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Chr. Hansen Immunity Support Ingredients Product Portfolio
  126. 7.21.5 Chr. Hansen Recent Developments
  127. 7.22 Excelvite
  128. 7.22.1 Excelvite Company Information
  129. 7.22.2 Excelvite Business Overview
  130. 7.22.3 Excelvite Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Excelvite Immunity Support Ingredients Product Portfolio
  132. 7.22.5 Excelvite Recent Developments
  133. 7.23 DDW
  134. 7.23.1 DDW Company Information
  135. 7.23.2 DDW Business Overview
  136. 7.23.3 DDW Immunity Support Ingredients Revenue and Gross Margin (2021-2026)
  137. 7.23.4 DDW Immunity Support Ingredients Product Portfolio
  138. 7.23.5 DDW Recent Developments
8 North America
  1. 8.1 North America Immunity Support Ingredients Revenue (2021-2032)
  2. 8.2 North America Immunity Support Ingredients Revenue by Type (2021-2032)
  3. 8.2.1 North America Immunity Support Ingredients Revenue by Type (2021-2026)
  4. 8.2.2 North America Immunity Support Ingredients Revenue by Type (2027-2032)
  5. 8.3 North America Immunity Support Ingredients Revenue Share by Type (2021-2032)
  6. 8.4 North America Immunity Support Ingredients Revenue by Application (2021-2032)
  7. 8.4.1 North America Immunity Support Ingredients Revenue by Application (2021-2026)
  8. 8.4.2 North America Immunity Support Ingredients Revenue by Application (2027-2032)
  9. 8.5 North America Immunity Support Ingredients Revenue Share by Application (2021-2032)
  10. 8.6 North America Immunity Support Ingredients Revenue by Country
  11. 8.6.1 North America Immunity Support Ingredients Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Immunity Support Ingredients Revenue by Country (2021-2026)
  13. 8.6.3 North America Immunity Support Ingredients Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Immunity Support Ingredients Revenue (2021-2032)
  2. 9.2 Europe Immunity Support Ingredients Revenue by Type (2021-2032)
  3. 9.2.1 Europe Immunity Support Ingredients Revenue by Type (2021-2026)
  4. 9.2.2 Europe Immunity Support Ingredients Revenue by Type (2027-2032)
  5. 9.3 Europe Immunity Support Ingredients Revenue Share by Type (2021-2032)
  6. 9.4 Europe Immunity Support Ingredients Revenue by Application (2021-2032)
  7. 9.4.1 Europe Immunity Support Ingredients Revenue by Application (2021-2026)
  8. 9.4.2 Europe Immunity Support Ingredients Revenue by Application (2027-2032)
  9. 9.5 Europe Immunity Support Ingredients Revenue Share by Application (2021-2032)
  10. 9.6 Europe Immunity Support Ingredients Revenue by Country
  11. 9.6.1 Europe Immunity Support Ingredients Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Immunity Support Ingredients Revenue by Country (2021-2026)
  13. 9.6.3 Europe Immunity Support Ingredients Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Immunity Support Ingredients Revenue (2021-2032)
  2. 10.2 China Immunity Support Ingredients Revenue by Type (2021-2032)
  3. 10.2.1 China Immunity Support Ingredients Revenue by Type (2021-2026)
  4. 10.2.2 China Immunity Support Ingredients Revenue by Type (2027-2032)
  5. 10.3 China Immunity Support Ingredients Revenue Share by Type (2021-2032)
  6. 10.4 China Immunity Support Ingredients Revenue by Application (2021-2032)
  7. 10.4.1 China Immunity Support Ingredients Revenue by Application (2021-2026)
  8. 10.4.2 China Immunity Support Ingredients Revenue by Application (2027-2032)
  9. 10.5 China Immunity Support Ingredients Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Immunity Support Ingredients Revenue (2021-2032)
  2. 11.2 Asia Immunity Support Ingredients Revenue by Type (2021-2032)
  3. 11.2.1 Asia Immunity Support Ingredients Revenue by Type (2021-2026)
  4. 11.2.2 Asia Immunity Support Ingredients Revenue by Type (2027-2032)
  5. 11.3 Asia Immunity Support Ingredients Revenue Share by Type (2021-2032)
  6. 11.4 Asia Immunity Support Ingredients Revenue by Application (2021-2032)
  7. 11.4.1 Asia Immunity Support Ingredients Revenue by Application (2021-2026)
  8. 11.4.2 Asia Immunity Support Ingredients Revenue by Application (2027-2032)
  9. 11.5 Asia Immunity Support Ingredients Revenue Share by Application (2021-2032)
  10. 11.6 Asia Immunity Support Ingredients Revenue by Country
  11. 11.6.1 Asia Immunity Support Ingredients Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Immunity Support Ingredients Revenue by Country (2021-2026)
  13. 11.6.3 Asia Immunity Support Ingredients Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Immunity Support Ingredients Revenue (2021-2032)
  2. 12.2 SAMEA Immunity Support Ingredients Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Immunity Support Ingredients Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Immunity Support Ingredients Revenue by Type (2027-2032)
  5. 12.3 SAMEA Immunity Support Ingredients Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Immunity Support Ingredients Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Immunity Support Ingredients Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Immunity Support Ingredients Revenue by Application (2027-2032)
  9. 12.5 SAMEA Immunity Support Ingredients Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Immunity Support Ingredients Revenue by Country
  11. 12.6.1 SAMEA Immunity Support Ingredients Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Immunity Support Ingredients Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Immunity Support Ingredients Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst